EFFECTS OF OFFERING ADVANCE DIRECTIVES ON MEDICAL TREATMENTS AND COSTS

被引:229
作者
SCHNEIDERMAN, LJ
KRONICK, R
KAPLAN, RM
ANDERSON, JP
LANGER, RD
机构
[1] Community and Family Medicine, University of California, San Diego, CA 92093-0622
关键词
ADVANCE DIRECTIVES; ETHICS; MEDICAL; PATIENT CARE PLANNING; COST CONTROL; TERMINAL CARE;
D O I
10.7326/0003-4819-117-7-599
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Objective: To examine the effects of advance directives on medical treatments and on patient satisfaction and well-being and to determine whether the enhancement of patient autonomy through advance directives provides a more ethically feasible approach to cost control than does the imposition of limits through rationing. Design: Randomized, controlled trial. Setting: University and Veterans Affairs medical center. Patients: Two hundred and four patients with life-threatening illnesses, 100 of whom died after enrollment in the study. Intervention: Patients randomly assigned to the experimental group were offered the California Durable Power of Attorney (a typical proxy-instruction directive), and patients assigned to the control group were not offered the advance directive. Hospital admissions were monitored to assure that a summary of the document was present in the active medical record at each hospitalization. Measurements: Cognitive function, patient satisfaction, pyschological well-being, health locus of control, sense of coherence, health-related quality of life, receipt of medical treatments, and medical treatment charges. Results: No significant differences were found between advance-directive and control groups regarding psychosocial variables, health outcome variables, and medical treatments or charges. Patients offered an advance directive had an average hospital stay of 40.8 days (95% Cl, 32.2 to 49.4 days), compared with an average of 33.1 days (95% Cl, 26.0 to 40.2 days) for controls. Patients offered an advance directive were charged an average of $19 502 (95% Cl, $13 030 to $25 974) for medical treatments in the last month of life compared with $19 700 (95% Cl, $13 704 to $25 696) for controls. Conclusions: Despite claims that public demand for longer life accounts for rising medical costs, most surveys suggest that patients are calling for less, not more, of the expensive, high-technology treatment often used in terminal phases of illness. Executing the California Durable Power of Attorney for Health Care and having a summary copy placed in the patient's medical record had no significant positive or negative effect on a patient's well-being, health status, medical treatments, or medical treatment charges.
引用
收藏
页码:599 / 606
页数:8
相关论文
共 36 条
[1]   CLASSIFYING FUNCTION FOR HEALTH OUTCOME AND QUALITY-OF-LIFE EVALUATION - SELF VERSUS INTERVIEWER MODES [J].
ANDERSON, JP ;
BUSH, JW ;
BERRY, CC .
MEDICAL CARE, 1986, 24 (05) :454-469
[2]  
[Anonymous], QUALITY LIFE ASSESSM
[3]  
ANTONOVSKY A, 1981, HLTH STRESS COPING
[4]   CHOICES ABOUT CARDIOPULMONARY RESUSCITATION IN THE HOSPITAL - WHEN DO PHYSICIANS TALK WITH PATIENTS [J].
BEDELL, SE ;
DELBANCO, TL .
NEW ENGLAND JOURNAL OF MEDICINE, 1984, 310 (17) :1089-1093
[5]   LIMITATIONS OF LISTING SPECIFIC MEDICAL INTERVENTIONS IN ADVANCE DIRECTIVES [J].
BRETT, AS .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1991, 266 (06) :825-828
[6]  
BUCHANA AE, 1989, DECIDING OTHERS ETHI
[7]  
CALLAHAN D, 1990, WHAT KIND LIFE LIMIT, P80
[8]   PATIENTS AND FAMILIES PREFERENCES FOR MEDICAL INTENSIVE-CARE [J].
DANIS, M ;
PATRICK, DL ;
SOUTHERLAND, LI ;
GREEN, ML .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1988, 260 (06) :797-802
[9]   A PROSPECTIVE-STUDY OF ADVANCE DIRECTIVES FOR LIFE-SUSTAINING CARE [J].
DANIS, M ;
SOUTHERLAND, LI ;
GARRETT, JM ;
SMITH, JL ;
HIELEMA, F ;
PICKARD, CG ;
EGNER, DM ;
PATRICK, DL .
NEW ENGLAND JOURNAL OF MEDICINE, 1991, 324 (13) :882-888
[10]  
DiMatteo M R, 1980, J Community Health, V6, P18